期刊文献+

妊娠合并甲状腺功能亢进症的诊治 被引量:15

Diagnosis and management of hyperthyroidism during pregnancy
原文传递
导出
摘要 妊娠合并甲状腺功能亢进症(甲亢)的发生率为0.1%~0.2%。最主要的病因是Graves病,是一种自身免疫性疾病。妊娠结局与是否治疗和严重程度有关。妊娠期甲亢的诊断有一定难度,游离T3或T4的水平升高,伴TSH水平降低能确诊为甲亢。一般是选择抗甲状腺药物治疗。 Thyrotoxicosis, or hyperthyroidism complicates about 0. 1% - 0.2% pregnancies. The over- whelming cause of thyrotoxicosis in pregnancy is Graves'disease, an organspecific autoimmune disease. Pregnancy outcomes in thyrotoxic women depend upon whether metabolic control is achieved. Mild thyrotoxieosis is difficult to diagnose during pregnancy. Clinical hypothyroidism is diagnosed if free thyroxine levels are low and the thyrotropin level is elevated. Thyrotoxicosis during pregnancy is generally treated medically.
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 2010年第6期409-411,共3页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 妊娠 甲状腺功能亢进症 pregnancy hyperthyroidism
  • 相关文献

参考文献7

  • 1曹泽毅.中华妇产科学[M].2版.北京:人民卫生出版社,2004:29.
  • 2Cooper DS. Hyperthyroidism[ J]. Lancet, 2003,362:459-468.
  • 3Mestman JH, Goodwin TM, Montoro MM. Thyroid-disorders of pregnancy[ J ]. Endocrinol Metab Clin North Am, 1995,24:41- 71.
  • 4Peleg D, Cada S, Peleg A, et al. The relationship between maternal serum thyroid-stimulating immunoglobulin and fetal and neonatal thyrotoxicosis [ J ]. Obstet Gynecol, 2002, 99 : 1040- 1043.
  • 5连小兰,白耀,徐蕴华,戴为信,郭芝生.妊娠合并甲状腺功能亢进症患者抗甲状腺药物治疗后对其新生儿先天畸形的影响[J].中华妇产科杂志,2005,40(8):511-515. 被引量:43
  • 6Casey BM, Dashe JS, Wells CE, et al. Subclinical hyperthyroidism and pregnancy outcomes [ J ]. Obstet Gynecol, 2006, 107:337-341.
  • 7Abalovich M, Amino N, Barbour LA, et al. Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society Clinical Practice Guideline[ J]. J Clin Endocrinol Metab, 2007,92(8 Suppl) :S1-47.

二级参考文献10

  • 1Cooper DS. Hyperthyroidism. Lancet, 2003,362 : 459-468.
  • 2American College of Obstetrics and Gynecology. ACOG practice bulletin. Thyroid disease in pregnancy. Number 37, August 2002.American College of Obstetrics and Gynecology. Int J Gynaecol Obstet ,2002,79 : 171-180.
  • 3Omotani N, Ito K, Hamada N, et al. Maternal hyperthyroidism and congenital malformation in the offspring. Clin Endocrinol, 1984,20 :695-700.
  • 4Wing DA, Millar LK, Koonings PP, et al. A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy. Am J Obstet Gynecol, 1994,170:90-95.
  • 5Clementi M, Di Gianantonio E, Pelo E, et al. Methimazole embryopathy: delineation of the phenotype. Am J Med Genet, 1999,83:43-46.
  • 6Martinez-Frias ML, Cereijo A, Rodriguez-Pinilla E, et al.Methimazole in the animal feed and congenital aplasis cutis. Lancet,1992, 339:742-743.
  • 7Mandel SJ, Cooper DS. The use of antithyroid drugs in pregnancy and lactation. J Clin Endocrinol Metab, 2001,86:2354-2359.
  • 8Diez-Delgado R j, Belmonte- Martin M J, Calvo-Bonachera MD, et al. Aplasia cutis as a teratogentic effect of methimazole. An Esp Pediatr, 1999,51 : 290-292.
  • 9Wilson LC, Kerr BA, Wilkinson R, et al. Choanal atresia and hypothelia following methimazole exposure in utero: a second report. Am J Med Genet, 1998,75:220-222.
  • 10Seoud M, Nassar A, Usta I, et aL Gastrointestinal malformations in two infants born to women with hyperthyroidism untreated in the first trimester. Am J Perinatol, 2003,20:59-62.

共引文献272

同被引文献117

引证文献15

二级引证文献58

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部